Workflow
Net asset value of the EfTEN United Property Fund as of 31.01.2026
Globenewswire· 2026-02-16 06:05
EfTEN United Property Fund earned a net profit of 223 thousand euros in January (the same period last year: 408 thousand euros). Decrease in profit was primarily related to the investment in EfTEN Real Estate Fund AS shares, which share price at Tallinn Stock Exchange increase by 2,9% in January 2026 as compared to 6,1% in January 2025. The net asset value (NAV) of the fund unit was 12,85 euros at the end of January, increasing by 0,8% per month. In Invego Uus-Järveküla OÜ, a development company in which th ...
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Globenewswire· 2026-02-16 06:00
MAJESTY, the first global phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years Up to 30% of people with membranous nephropathy progress to kidney failure over 10 years despite current treatment approaches; achieving complete remission can help delay or prevent this1,2Gazyva/Gazyvaro could become the first approved treatment for primary membranous nephropathy, having already achieved positive results in lupus nephritis, systemic lupus erythematosus an ...
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Globenewswire· 2026-02-16 06:00
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer RSV hospitalizations in their second season The study also showed a reduction of 85.9% in RSV-related lower respiratory tract infection hospitalizations in the first season Data published in The Lancet Infectious Diseases and to be presented at RSVVW ’26 conference in Rome Paris, February 16, 2026. A universal re ...
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Globenewswire· 2026-02-16 06:00
MAJESTY, the first global phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years Up to 30% of people with membranous nephropathy progress to kidney failure over 10 years despite current treatment approaches; achieving complete remission can help delay or prevent this1,2Gazyva/Gazyvaro could become the first approved treatment for primary membranous nephropathy, having already achieved positive results in lupus nephritis, systemic lupus erythematosus an ...
Cognizant Expands Strategic Partnership with Google Cloud to Operationalize Agentic AI at Enterprise Scale
Prnewswire· 2026-02-16 06:00
Cognizant Expands Strategic Partnership with Google Cloud to Operationalize Agentic AI at Enterprise Scale [Accessibility Statement] Skip NavigationThrough its AI builder approach and proprietary capabilities built on Google Cloud, Cognizant is enabling enterprises to translate AI strategy into deployed, governed systems at scale.TEANECK, N.J., Feb. 16, 2026 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) announced a new phase in its strategic partnership with Google Cloud, advancing from platform integration to e ...
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Globenewswire· 2026-02-16 06:00
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer RSV hospitalizations in their second season The study also showed a reduction of 85.9% in RSV-related lower respiratory tract infection hospitalizations in the first season Data published in The Lancet Infectious Diseases and to be presented at RSVVW ’26 conference in Rome Paris, February 16, 2026. A universal re ...
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
Businesswire· 2026-02-16 06:00
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MAJESTY study in adults with primary membranous nephropathy met its primary endpoint, showing statistically significant and clinically meaningful results with Gazyva® (obinutuzumab). Results show that significantly more people achieved complete remission at two years (104 weeks) with Gazyva versus tacrolimus. Safety was in line with the well-charac. ...
Waste Management: A Top Defensive Stock For A Bumpy 2026
Seeking Alpha· 2026-02-16 05:58
Core Viewpoint - The analyst maintains a buy rating on Waste Management, Inc. (WM) and expresses confidence in the company's fundamentals and outlook, noting an 8% increase in stock price since the last update [1] Company Performance - Waste Management, Inc. has shown a positive stock performance, with an increase of approximately 8% since the analyst's last update in late November 2025 [1]
Grindr's Former Board Chair Sells 1.45M Shares After Buyout Negotations End
The Motley Fool· 2026-02-16 05:55
Grindr was on the verge of going private after its majority owners sought to take it off the public market. But after those talks subsided, one of the majority owners sold shares. On Feb. 4, 5, and 6, 2026, majority owner James Fu Bin Lu, more commonly known as James Lu, disposed of 1.45 million shares of Grindr Inc. (GRND +2.18%) in a series of open-market sales, as reported in a SEC Form 4 filing. Transaction summary | Metric | Value | | --- | --- | | Shares sold (indirect) | 1,450,000 | | Transaction val ...
January's Gains Endure as High Supply Tempers February U.K. House-Price Growth, Rightmove Says
WSJ· 2026-02-16 05:50
Core Viewpoint - The U.K. housing market experienced virtually flat house prices in February due to a high inventory of homes for sale and stable buyer activity [1] Group 1: Market Conditions - A high choice of homes for sale contributed to the stabilization of house prices [1] - Steady buyer activity played a significant role in preventing any increase in house prices [1]